Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		249,567,000
Beginning balance at Dec. 31, 2022	$ 833,252	$ 25	$ 1,608,306	$ (7,599)	$ (767,480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,479,000
Issuance of common stock upon exercise of stock options	155		155
Issuance of common stock under employee stock purchase plan (in shares)		543,000
Issuance of common stock under employee stock purchase plan	1,163		1,163
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		280,000
Issuance of common stock in connection with restricted stock units, net of tax	(334)		(334)
Stock-based compensation	38,621		38,621
Other comprehensive income	6,418			6,418
Net loss	(181,702)				(181,702)
Ending balance (in shares) at Sep. 30, 2023		251,869,000
Ending balance at Sep. 30, 2023	697,573	$ 25	1,647,911	(1,181)	(949,182)
Beginning balance (in shares) at Jun. 30, 2023		251,027,000
Beginning balance at Jun. 30, 2023	736,855	$ 25	1,637,538	(2,379)	(898,329)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		646,000
Issuance of common stock upon exercise of stock options	72		72
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		196,000
Issuance of common stock in connection with restricted stock units, net of tax	(215)		(215)
Stock-based compensation	10,516		10,516
Other comprehensive income	1,198			1,198
Net loss	(50,853)				(50,853)
Ending balance (in shares) at Sep. 30, 2023		251,869,000
Ending balance at Sep. 30, 2023	$ 697,573	$ 25	1,647,911	(1,181)	(949,182)
Beginning balance (in shares) at Dec. 31, 2023	253,957,709	253,958,000
Beginning balance at Dec. 31, 2023	$ 654,952	$ 25	1,657,133	(94)	(1,002,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,245,836	1,246,000
Issuance of common stock upon exercise of stock options	$ 155	$ 1	154
Issuance of common stock under employee stock purchase plan (in shares)		491,000
Issuance of common stock under employee stock purchase plan	810		810
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		869,000
Issuance of common stock in connection with restricted stock units, net of tax	(76)		(76)
Stock-based compensation	25,061		25,061
Other comprehensive income	854			854
Net loss	$ (151,059)				(151,059)
Ending balance (in shares) at Sep. 30, 2024	256,563,684	256,564,000
Ending balance at Sep. 30, 2024	$ 530,697	$ 26	1,683,082	760	(1,153,171)
Beginning balance (in shares) at Jun. 30, 2024		255,948,000
Beginning balance at Jun. 30, 2024	566,501	$ 26	1,675,460	(397)	(1,108,588)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		616,000
Stock-based compensation	7,622		7,622
Other comprehensive income	1,157			1,157
Net loss	$ (44,583)				(44,583)
Ending balance (in shares) at Sep. 30, 2024	256,563,684	256,564,000
Ending balance at Sep. 30, 2024	$ 530,697	$ 26	$ 1,683,082	$ 760	$ (1,153,171)